{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:22:29Z","timestamp":1786980149398,"version":"build-2736575974"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s00417-023-06281-0","type":"journal-article","created":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T03:02:22Z","timestamp":1698807742000},"page":"1281-1288","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Topical ivermectin ointment treatment of Demodex blepharitis: a 6-year retrospective study"],"prefix":"10.1007","volume":"262","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-2060-890X","authenticated-orcid":false,"given":"Florencia","family":"Valvecchia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes","family":"Greco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celina","family":"Logioco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaston Gomez","family":"Caride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Valvecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Albertazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Zanutigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,1]]},"reference":[{"key":"6281_CR1","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1001\/archderm.1963.01590210056008","volume":"88","author":"PT CF","year":"1963","unstructured":"CF PT, Juhlin E (1963) Demodex folliculorum and blepharitis. Arch Dermatol 88:298\u2013302. https:\/\/doi.org\/10.1001\/archderm.1963.01590210056008","journal-title":"Arch Dermatol"},{"key":"6281_CR2","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/0002-9394(81)90291-9","volume":"91","author":"FP English","year":"1981","unstructured":"English FP, Nutting WB (1981) Demodicosis of ophthalmic concern. Am J Ophthalmol 91:362\u2013372. https:\/\/doi.org\/10.1016\/0002-9394(81)90291-9","journal-title":"Am J Ophthalmol"},{"key":"6281_CR3","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.clindermatol.2014.02.012","volume":"32","author":"CA Elston","year":"2014","unstructured":"Elston CA, Elston DM (2014) Demodex mites. Clin Dermatol 32:739\u2013743. https:\/\/doi.org\/10.1016\/j.clindermatol.2014.02.012","journal-title":"Clin Dermatol"},{"key":"6281_CR4","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s10792-016-0249-9","volume":"37","author":"SG Nicholls","year":"2017","unstructured":"Nicholls SG, Oakley CL, Tan A, Vote BJ (2017) Demodex species in human ocular disease: new clinicopathological aspects. Int Ophthalmol 37:303\u2013312. https:\/\/doi.org\/10.1007\/s10792-016-0249-9","journal-title":"Int Ophthalmol"},{"key":"6281_CR5","doi-asserted-by":"publisher","unstructured":"Ayres BD, Donnenfeld E, Farid M, Gaddie IB, Gupta PK, Holland E, Karpecki PM, Lindstrom R, Nichols KK, Pflugfelder SC, Starr CE, Yeu E (2023) Clinical diagnosis and management of Demodex blepharitis: the Demodex Expert Panel on Treatment and Eyelid Health (DEPTH). Eye (Lond). https:\/\/doi.org\/10.1038\/s41433-023-02500-4","DOI":"10.1038\/s41433-023-02500-4"},{"issue":"17","key":"6281_CR6","doi-asserted-by":"publisher","first-page":"667","DOI":"10.2147\/OPTH.S399989","volume":"27","author":"M Farid","year":"2023","unstructured":"Farid M, Ayres BD, Donnenfeld E, Gaddie IB, Gupta PK, Holland E, Lindstrom R, Pflugfelder SC, Karpecki PM, Nichols KK, Starr CE, Yeu E (2023) Delphi panel consensus regarding current clinical practice management options for Demodex blepharitis. Clin Ophthalmol 27(17):667\u2013679. https:\/\/doi.org\/10.2147\/OPTH.S399989","journal-title":"Clin Ophthalmol"},{"key":"6281_CR7","doi-asserted-by":"publisher","first-page":"101551","DOI":"10.1016\/j.ajoc.2022.101551","volume":"26","author":"CJ Helm","year":"2022","unstructured":"Helm CJ (2022) Treatment of ocular Demodex infestation with topical ivermectin cream. Am J Ophthalmol Case Rep 26:101551. https:\/\/doi.org\/10.1016\/j.ajoc.2022.101551","journal-title":"Am J Ophthalmol Case Rep"},{"key":"6281_CR8","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/ICO.0000000000002802","volume":"41","author":"Y Choi","year":"2022","unstructured":"Choi Y, Eom Y, Yoon EG, Song JS, Kim IH, Kim HM (2022) Efficacy of topical ivermectin 1% in the treatment of Demodex blepharitis. Cornea 41:427\u2013434. https:\/\/doi.org\/10.1097\/ICO.0000000000002802","journal-title":"Cornea"},{"key":"6281_CR9","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1167\/iovs.05-0275","volume":"46","author":"YY Gao","year":"2005","unstructured":"Gao YY, Di Pascuale MA, Li W, Liu DT, Baradaran-Rafii A, Elizondo A, Kawakita T, Raju VK, Tseng SC (2005) High prevalence of Demodex in eyelashes with cylindrical dandruff. Invest Ophthalmol Vis Sci 46:3089\u20133094. https:\/\/doi.org\/10.1167\/iovs.05-0275","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"6281_CR10","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.pt.2017.02.004","volume":"33","author":"R Laing","year":"2017","unstructured":"Laing R, Gillan V, Devaney E (2017) Ivermectin - old drug, new tricks? Trends Parasitol 33:463\u2013472. https:\/\/doi.org\/10.1016\/j.pt.2017.02.004","journal-title":"Trends Parasitol"},{"key":"6281_CR11","doi-asserted-by":"publisher","first-page":"15773","DOI":"10.1073\/pnas.1520952112","volume":"112","author":"WC Van Voorhis","year":"2015","unstructured":"Van Voorhis WC (2015) Profile of William C. Campbell, Satoshi Omura, and Youyou Tu, 2015 Nobel Laureates in physiology or medicine. Proc Natl Acad Sci U S A 112:15773\u201315776","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6281_CR12","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.6308762","volume":"221","author":"WC Campbell","year":"1983","unstructured":"Campbell WC (1983) Ivermectin: a potent new antiparasitic agent. Science 221:823\u2013828","journal-title":"Science"},{"key":"6281_CR13","doi-asserted-by":"publisher","unstructured":"Cupp EW, Sauerbrey M, Richards F (2010) Elimination of human onchocerciasis: history of progress and current feasibility using ivermectin (Mectizan(\u00ae)) monotherapy. Acta Trop. https:\/\/doi.org\/10.1016\/j.actatropica.2010.08.009","DOI":"10.1016\/j.actatropica.2010.08.009"},{"key":"6281_CR14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.pt.2020.10.005","volume":"37","author":"RJ Martin","year":"2021","unstructured":"Martin RJ, Robertson AP, Choudhary S (2021) Ivermectin: an anthelmintic, an insecticide, and much more. Trends Parasitol 37:48\u201364. https:\/\/doi.org\/10.1016\/j.pt.2020.10.005","journal-title":"Trends Parasitol"},{"key":"6281_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10787-022-01129-1","volume":"31","author":"M Nabi-Afjadi","year":"2023","unstructured":"Nabi-Afjadi M, Mohebi F, Zalpoor H, Aziziyan F, Akbari A, Moradi-Sardareh H, Bahreini E, Moeini AM, Effatpanah H (2023) A cellular and molecular biology-based update for ivermectin against COVID-19: is it effective or non-effective? Inflammopharmacology 31:21\u201335. https:\/\/doi.org\/10.1007\/s10787-022-01129-1","journal-title":"Inflammopharmacology"},{"key":"6281_CR16","first-page":"1","volume":"26","author":"CN Kang","year":"2021","unstructured":"Kang CN, Shah M, Tan J (2021) Rosacea: an update in diagnosis, classification and management. Skin Therapy Lett 26:1\u20138","journal-title":"Skin Therapy Lett"},{"key":"6281_CR17","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s13555-018-0249-y","volume":"8","author":"CCF Ebbelaar","year":"2018","unstructured":"Ebbelaar CCF, Venema AW, Van Dijk MR (2018) Topical ivermectin in the treatment of papulopustular rosacea: a systematic review of evidence and clinical guideline recommendations. Dermatol Ther (Heidelb) 8:379\u2013387. https:\/\/doi.org\/10.1007\/s13555-018-0249-y","journal-title":"Dermatol Ther (Heidelb)"},{"key":"6281_CR18","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1080\/14656566.2018.1447562","volume":"19","author":"DR Sahni","year":"2018","unstructured":"Sahni DR, Feldman SR, Taylor SL (2018) Ivermectin 1% (CD5024) for the treatment of rosacea. Expert Opin Pharmacother 19:511\u2013516. https:\/\/doi.org\/10.1080\/14656566.2018.1447562","journal-title":"Expert Opin Pharmacother"},{"key":"6281_CR19","first-page":"325","volume":"15","author":"LH Kircik","year":"2016","unstructured":"Kircik LH, Del Rosso JQ, Layton AM, Schauber J (2016) Over 25 Years of Clinical Experience With Ivermectin: An overview of safety for an increasing number of indications. J Drugs Dermatol 15:325\u2013332","journal-title":"J Drugs Dermatol"},{"key":"6281_CR20","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/cxo.13123","volume":"104","author":"E Bitton","year":"2021","unstructured":"Bitton E, Aumond S (2021) Demodex and eye disease: a review. Clin Exp Optom 104:285\u2013294. https:\/\/doi.org\/10.1111\/cxo.13123","journal-title":"Clin Exp Optom"},{"key":"6281_CR21","doi-asserted-by":"publisher","first-page":"631","DOI":"10.4321\/s0365-66912006001100002","volume":"81","author":"A Corral Arag\u00f3n","year":"2006","unstructured":"Corral Arag\u00f3n A (2006) La formulaci\u00f3n magistral en oftalmolog\u00eda: una necesidad terap\u00e9utica [Pharmaceutical compounding in ophthalmology: a therapeutic need]. Arch Soc Esp Oftalmol 81:631\u2013632. https:\/\/doi.org\/10.4321\/s0365-66912006001100002","journal-title":"Arch Soc Esp Oftalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-023-06281-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-023-06281-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-023-06281-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T04:04:43Z","timestamp":1712203483000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-023-06281-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,1]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["6281"],"URL":"https:\/\/doi.org\/10.1007\/s00417-023-06281-0","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,1]]},"assertion":[{"value":"1 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study adhered to the tenets of the Declaration of Helsinki, and the Centro de Ojos Quilmes ethics committee approved the design of this study. Informed consent was obtained from every patient before starting the treatment: the participating patients previously signed an informed consent form, explaining that a drug would be used off-label, that their data would be evaluated for scientific research purposes, and that the results would be published in academic fields while protecting their identity.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors approved the final manuscript for submission.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}